Eads & Heald Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.13M | Sell |
4,331
-12
| -0.3% | -$6.51K | 1.06% | 35 |
|
|
2025
Q4 | $2.52M | Sell |
4,343
-11
| -0.3% | -$6.22K | 1.22% | 25 |
|
|
2025
Q3 | $2.11M | Sell |
4,354
-17
| -0.4% | -$7.91K | 1.01% | 34 |
|
|
2025
Q2 | $1.77M | Sell |
4,371
-92
| -2% | -$38.5K | 0.88% | 48 |
|
|
2025
Q1 | $2.22M | Sell |
4,463
-49
| -1% | -$26.5K | 1.13% | 29 |
|
|
2024
Q4 | $2.35M | Buy |
4,512
+37
| +0.8% | +$20.3K | 1.15% | 28 |
|
|
2024
Q3 | $2.77M | Sell |
4,475
-234
| -5% | -$139K | 1.31% | 16 |
|
|
2024
Q2 | $2.6M | Sell |
4,709
-47
| -1% | -$26.9K | 1.26% | 20 |
|
|
2024
Q1 | $2.76M | Sell |
4,756
-284
| -6% | -$159K | 1.29% | 19 |
|
|
2023
Q4 | $2.67M | Sell |
5,040
-30
| -0.6% | -$14.5K | 1.29% | 22 |
|
|
2023
Q3 | $2.57M | Sell |
5,070
-123
| -2% | -$65.5K | 1.35% | 17 |
|
|
2023
Q2 | $2.71M | Sell |
5,193
-277
| -5% | -$149K | 1.33% | 18 |
|
|
2023
Q1 | $3.15M | Sell |
5,470
-59
| -1% | -$33.3K | 1.56% | 3 |
|
|
2022
Q4 | $3.04M | Buy |
5,529
+18
| +0.3% | +$9.54K | 1.55% | 3 |
|
|
2022
Q3 | $2.79M | Sell |
5,511
-190
| -3% | -$106K | 1.59% | 5 |
|
|
2022
Q2 | $3.1M | Sell |
5,701
-78
| -1% | -$42.9K | 1.67% | 2 |
|
|
2022
Q1 | $3.41M | Sell |
5,779
-220
| -4% | -$126K | 1.58% | 3 |
|
|
2021
Q4 | $4M | Sell |
5,999
-187
| -3% | -$117K | 1.74% | 3 |
|
|
2021
Q3 | $3.53M | Sell |
6,186
-239
| -4% | -$131K | 1.71% | 1 |
|
|
2021
Q2 | $3.24M | Sell |
6,425
-51
| -0.8% | -$24.1K | 1.58% | 3 |
|
|
2021
Q1 | $2.96M | Sell |
6,476
-145
| -2% | -$69.2K | 1.52% | 3 |
|
|
2020
Q4 | $3.08M | Sell |
6,621
-418
| -6% | -$196K | 1.66% | 3 |
|
|
2020
Q3 | $3.11M | Sell |
7,039
-1,143
| -14% | -$472K | 1.86% | 3 |
|
|
2020
Q2 | $2.96M | Sell |
8,182
-319
| -4% | -$107K | 1.8% | 3 |
|
|
2020
Q1 | $2.41M | Sell |
8,501
-745
| -8% | -$235K | 1.7% | 5 |
|
|
2019
Q4 | $3M | Sell |
9,246
-117
| -1% | -$35.5K | 1.59% | 3 |
|
|
2019
Q3 | $2.73M | Sell |
9,363
-305
| -3% | -$87.3K | 1.52% | 5 |
|
|
2019
Q2 | $2.84M | Sell |
9,668
-568
| -6% | -$156K | 1.61% | 2 |
|
|
2019
Q1 | $2.8M | Sell |
10,236
-451
| -4% | -$112K | 1.62% | 1 |
|
|
2018
Q4 | $2.39M | Sell |
10,687
-441
| -4% | -$103K | 1.59% | 2 |
|
|
2018
Q3 | $2.72M | Sell |
11,128
-393
| -3% | -$90.4K | 1.56% | 4 |
|
|
2018
Q2 | $2.39M | Sell |
11,521
-146
| -1% | -$31K | 1.47% | 11 |
|
|
2018
Q1 | $2.41M | Sell |
11,667
-828
| -7% | -$174K | 1.53% | 5 |
|
|
2017
Q4 | $2.37M | Sell |
12,495
-97
| -0.8% | -$18.6K | 1.4% | 10 |
|
|
2017
Q3 | $2.38M | Sell |
12,592
-781
| -6% | -$141K | 1.48% | 5 |
|
|
2017
Q2 | $2.33M | Sell |
13,373
-635
| -5% | -$107K | 1.5% | 4 |
|
|
2017
Q1 | $2.15M | Sell |
14,008
-126
| -0.9% | -$19.3K | 1.39% | 12 |
|
|
2016
Q4 | $1.99M | Sell |
14,134
-89
| -0.6% | -$13.1K | 1.36% | 12 |
|
|
2016
Q3 | $2.26M | Sell |
14,223
-382
| -3% | -$58.9K | 1.56% | 2 |
|
|
2016
Q2 | $2.16M | Sell |
14,605
-738
| -5% | -$109K | 1.48% | 5 |
|
|
2016
Q1 | $2.17M | Sell |
15,343
-700
| -4% | -$93.8K | 1.5% | 1 |
|
|
2015
Q4 | $2.28M | Sell |
16,043
-276
| -2% | -$36.8K | 1.58% | 2 |
|
|
2015
Q3 | $2M | Sell |
16,319
-402
| -2% | -$52.4K | 1.42% | 9 |
|
|
2015
Q2 | $2.17M | Sell |
16,721
-279
| -2% | -$36.4K | 1.43% | 4 |
|
|
2015
Q1 | $2.28M | Sell |
17,000
-594
| -3% | -$76.6K | 1.47% | 5 |
|
|
2014
Q4 | $2.2M | Buy |
17,594
+220
| +1% | +$26.8K | 1.4% | 11 |
|
|
2014
Q3 | $2.11M | Sell |
17,374
-922
| -5% | -$112K | 1.43% | 8 |
|
|
2014
Q2 | $2.16M | Sell |
18,296
-1,761
| -9% | -$207K | 1.43% | 12 |
|
|
2014
Q1 | $2.41M | Sell |
20,057
-3,004
| -13% | -$357K | 1.59% | 2 |
|
|
2013
Q4 | $2.57M | Sell |
23,061
-1,224
| -5% | -$122K | 1.7% | 2 |
|
|
2013
Q3 | $2.24M | Sell |
24,285
-5,438
| -18% | -$492K | 1.6% | 1 |
|
|
2013
Q2 | $2.52M | Buy |
+29,723
| New | +$2.47M | 1.78% | 1 |
|
Other funds holding TMO
VCM
Eads & Heald Wealth Management's TMO Position: Q1 2026 in Review
Eads & Heald Wealth Management reduced its Thermo Fisher Scientific (TMO) stake by 0.28% in Q1 2026, selling an estimated $6.51K and leaving 4,331 shares worth $2.13M. The position accounts for 1.06% of the portfolio, ranked #35.
Eads & Heald Wealth Management first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $4M in Q4 2021. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Eads & Heald Wealth Management held 4,331 shares of Thermo Fisher Scientific worth $2.13M as of Q1 2026.
- Eads & Heald Wealth Management sold 12 Thermo Fisher Scientific shares in Q1 2026, an estimated $6.51K.
- Thermo Fisher Scientific made up 1.06% of Eads & Heald Wealth Management's portfolio in Q1 2026, its #35 holding.
- Eads & Heald Wealth Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
- Eads & Heald Wealth Management's Thermo Fisher Scientific position peaked at $4M in Q4 2021.
- 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Eads & Heald Wealth Management's 13F filing for Q1 2026, filed 29 Apr 2026.